Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does GANCICLOVIR Cause Transplant rejection? 81 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 81 reports of Transplant rejection have been filed in association with GANCICLOVIR (Ganciclovir). This represents 1.6% of all adverse event reports for GANCICLOVIR.

81
Reports of Transplant rejection with GANCICLOVIR
1.6%
of all GANCICLOVIR reports
25
Deaths
41
Hospitalizations

How Dangerous Is Transplant rejection From GANCICLOVIR?

Of the 81 reports, 25 (30.9%) resulted in death, 41 (50.6%) required hospitalization, and 6 (7.4%) were considered life-threatening.

Is Transplant rejection Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for GANCICLOVIR. However, 81 reports have been filed with the FAERS database.

What Other Side Effects Does GANCICLOVIR Cause?

Off label use (1,104) Drug ineffective (924) Cytomegalovirus infection (668) Drug resistance (594) Pancytopenia (403) Product use in unapproved indication (400) Neutropenia (396) Cytomegalovirus infection reactivation (301) Cytomegalovirus viraemia (294) Product use issue (279)

What Other Drugs Cause Transplant rejection?

TACROLIMUS (3,526) MYCOPHENOLATE MOFETIL (2,500) PREDNISONE (1,111) CYCLOSPORINE (903) PREDNISOLONE (860) METHYLPREDNISOLONE (779) SIROLIMUS (698) BASILIXIMAB (554) MYCOPHENOLIC ACID (445) LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN (437)

Which GANCICLOVIR Alternatives Have Lower Transplant rejection Risk?

GANCICLOVIR vs GANIRELIX GANCICLOVIR vs GATIFLOXACIN GANCICLOVIR vs GEFITINIB GANCICLOVIR vs GELATIN GANCICLOVIR vs GEMCITABINE

Related Pages

GANCICLOVIR Full Profile All Transplant rejection Reports All Drugs Causing Transplant rejection GANCICLOVIR Demographics